相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Safety of Long-Term Bisphosphonate Therapy for the Management of Osteoporosis
E. Michael Lewiecki
DRUGS (2011)
Bisphosphonates for post-menopausal osteoporosis: are they all the same?
R. Rizzoli
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2011)
Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis
I. Imaz et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Persistence and switching patterns among women with varied osteoporosis medication histories: 12-month results from POSSIBLE US™
A. N. A. Tosteson et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Weekly versus monthly drug regimens: 1-year compliance and persistence with bisphosphonate therapy
Deborah T. Gold et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis
Prajesh Kothawala et al.
MAYO CLINIC PROCEEDINGS (2007)
Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: Relationship to vertebral and nonvertebral fractures from 2 US claims databases
Ethel S. Siris et al.
MAYO CLINIC PROCEEDINGS (2006)
Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study
A. Cooper et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Assessment of compliance with osteoporosis treatment and its consequences in a managed care population
KF Huybrechts et al.
BONE (2006)
Compliance with drug therapies for the treatment and prevention of osteoporosis
JS McCombs et al.
MATURITAS (2004)
Early discontinuation of treatment for osteoporosis
ANA Tosteson et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: A multicenter, randomized, open-label, crossover study
JA Simon et al.
CLINICAL THERAPEUTICS (2002)